Episodes

In this episode, Moshim Kukar, MD FACS FSSO, Professor and Chair, Surgical Oncology, Program Director, Complex General Surgical Oncology Fellowship, Roswell Park Comprehensive Cancer Center, discusses how specialized teams, robotic surgery, and structured training improve surgical outcomes.

In this episode, Dr. Noran Barry, Dual-Trained Breast Surgical Oncology & Surgical Critical Care UC Berkeley MPH student, discusses robotic nipple sparing mastectomy, advances in breast reconstruction, and how health systems can expand access to innovative, patient centered breast cancer care.

In this episode, David Albala, MD, Chief of Urology at Crouse Hospital and physician with the Associated Medical Professionals of New York, discusses how AI is improving prostate cancer detection, personalizing treatment decisions and helping physicians deliver better outcomes. He also shares what gives him hope for the future of prostate cancer care.

In this episode, Diane M. Simeone, MD, Director, Moores Cancer Center, Koman Family Presidential Director’s Chair, UC San Diego Health, discusses streamlining clinical trials, using AI to accelerate trial activation, and expanding access to innovative cancer treatments.

In this episode, Anirban Maitra, MD, Director of Perlmutter Cancer Center at NYU Langone Health, joins the podcast to discuss expanding cancer care to bring services closer to patients and communities. He also shares insights on integrating AI into oncology and how emerging technologies are enhancing training and preparing the next generation of cancer care professionals.

In this episode, Monica L. Baskin, PhD, Director of VCU Massey Comprehensive Cancer Center, joins the podcast to discuss the center’s Cancer Center Support Grant renewal and the work underway at Massey to advance cancer care and research. She also shares her experience as the first Black woman to be named director of an NCI-designated cancer center and the significance of that milestone.

In this episode, Shridar Ganesan, MD, Director, Center for Molecular Oncology at NYU Langone Health, discusses integrating genomic, clinical and radiographic data to improve cancer care and the role of AI in synthesizing complex patient information. He also explores the future of molecularly defined cancers, targeted therapies and the need to balance standard care with clinical research.

In this episode, Ajay Goel, PhD, AGAF, Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope, discusses a promising blood-based test that detected 81% of advanced precancerous colorectal lesions and explores how earlier detection could shift cancer care toward prevention. He also examines screening access, reimbursement, follow-up care and the growing role of liquid biopsies in the future of oncology.

In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, Senior Vice President, Cancer Nursing, Winship Cancer Institute of Emory University, discusses balancing the growing complexity of cancer care with patient expectations for accessible, coordinated care. She also explores AI in oncology, the evolving role of nursing, care navigation, risk stratification and the future of survivorship.

In this episode, Boris Pasche, MD, PhD, FACP, President and Chief Executive Officer of Barbara Ann Karmanos Cancer Institute and Oncology Department Chair at Wayne State University, joins the podcast to discuss navigating uncertainty in today’s healthcare environment. He shares insights on evolving therapy services and highlights emerging breakthroughs in oncology that are shaping the future of cancer care.

In this episode, Robert Stone, Chief Executive Officer, Helen and Morgan Chu Chief Executive Officer Distinguished Chair, City of Hope, discusses the organization’s approach to expanding cancer care access, building philanthropic partnerships and keeping patients at the center of growth. He also shares his perspective on AI, technology and the future of cancer treatment.

In this episode, Thomas Lynch, MD, President and Chief Executive Officer of Fred Hutchinson Cancer Center, joins the podcast to discuss expanding outpatient capacity to meet growing demand for cancer care while improving access and the patient experience. He also shares his perspective on preparing the next generation of physicians, highlighting the importance of education, mentorship, and innovation in shaping the future of oncology.

In this episode, Alyssia Crews, MBA, FACHE, Vice President of Orlando Health Cancer Institute, joins the podcast to discuss expanding access to cancer care and improving clinical access for patients across the communities the institute serves. She shares insights on addressing workforce and staffing challenges, as well as the key operational and strategic issues oncology leaders are navigating to deliver high-quality, patient-centered care in a rapidly evolving healthcare landscape.

In this episode, Jodi Skiles, MD, Medical Director of the Pediatric Stem Cell Transplant Program at Riley Hospital for Children in Indianapolis, joins the podcast to discuss a groundbreaking milestone in pediatric medicine—the world's first bone marrow stem cell transplant using cells from a deceased donor in a 14-year-old patient. She shares the significance of expanding access to this innovative donor source and how advances in transplant medicine are creating new opportunities to improve outc...

In this episode, Dr. James McGee, Osf Healthcare Cancer Institute, discusses the urgent need to expand cancer prevention and early detection in rural communities while addressing the unique challenges rural providers face. He also shares his perspective on AI in oncology, the growing impact of obesity on cancer care, and emerging innovations that could improve access and reduce the cost of treatment.

In this episode, Jordan Johnson, MSHA, Bridge Oncology, ABA Health Law Oncology Advocacy, discusses the major CMS policy shifts reshaping oncology, the growing role of AI governance, and why healthcare leaders must think beyond reimbursement rates to prepare for the future of care delivery. He also shares advice for entrepreneurs on building systems thinking across finance, clinical care, compliance, and technology.

In this episode, Frantz M. Berthaud, MPH, FACHE, Senior Vice President, Oncology Services, University Medical Center of El Paso (UMC), discusses why cancer care leaders should measure both return on investment and return on humanity. He also shares insights on expanding oncology capacity, advancing health equity, and building a workforce and culture centered on compassionate, patient-focused care.

In this episode, Jeffrey E. Lee, M.D., Executive Vice President, Chief Physician Executive, The University of Texas MD Anderson, discusses how advances in cancer treatment are transforming survivorship care by improving outcomes while reducing treatment burden. He shares MD Anderson's approach to supporting patients beyond remission through personalized care, survivorship programs, and innovations that prioritize both longevity and quality of life.

In this episode, Theodoros Teknos, MD, President & Scientific Director of University Hospitals Seidman Cancer Center and the Jane and Lee Seidman Chair in Cancer Innovation, discusses the importance of recruiting top oncology talent, balancing research with clinical care, and using AI to improve patient outcomes. He also shares why continued investment in cancer research and scientific discovery is critical to accelerating the next generation of cancer breakthroughs.

In this episode, Dr. Robert Winn, Cancer Center Director at Fox Chase Cancer Center, Temple Health, shares his vision for expanding access to cutting edge cancer research by strengthening community partnerships and building trust in science. He also discusses the future of clinical trials, AI driven drug discovery, and accelerating innovation to improve cancer outcomes.

In this episode, Dr. Robert Figlin, Cedars-Sinai Cancer Institute, discusses improving patient access to specialized cancer care, expanding clinical trial opportunities, and using AI to streamline care delivery. He also shares why advances in research and innovation are giving oncology leaders more reason for optimism than ever before.

In this episode, Richard Barakat, MD, Physician-in-chief & Executive Director at Northwell Health Cancer Institute, discusses expanding access to advanced cancer therapies, integrating AI into oncology care, and driving the future of precision medicine. He also shares insights on improving efficiency, survivorship care, and clinical trial access for all patients.